An Open-Label, Dose-Escalation Study to Assess the Safety and Efficacy of IL-22 Agonist F-652 in Patients With Alcohol-associated Hepatitis
dc.contributor.author | Arab Verdugo, Juan Pablo | |
dc.contributor.author | Sehrawat, T. S. | |
dc.contributor.author | Simonetto, D. A. | |
dc.contributor.author | Verma, V. K. | |
dc.contributor.author | Feng, D. C. | |
dc.contributor.author | Tang, T. | |
dc.contributor.author | Dreyer, K. | |
dc.contributor.author | Yan, X. Q. | |
dc.contributor.author | Daley, W. L. | |
dc.contributor.author | Ibacache Figueroa, Mauricio Enrique | |
dc.contributor.author | Sanyal, A. | |
dc.contributor.author | Chalasani, N. | |
dc.contributor.author | Radaeva, S. | |
dc.contributor.author | Yang, L. | |
dc.contributor.author | Vargas, H. | |
dc.contributor.author | Gao, B. | |
dc.contributor.author | Gores, G. J. | |
dc.contributor.author | Malhi, H. | |
dc.contributor.author | Kamath, P. S. | |
dc.contributor.author | Shah, V. H. | |
dc.date.accessioned | 2021-09-10T19:56:33Z | |
dc.date.available | 2021-09-10T19:56:33Z | |
dc.date.issued | 2020 | |
dc.fechaingreso.objetodigital | 2025-01-03 | |
dc.format.extent | 13 páginas | |
dc.fuente.origen | Converis | |
dc.identifier.doi | 10.1002/hep.31046 | |
dc.identifier.issn | 0270-9139 | |
dc.identifier.pubmedid | 31774566 | |
dc.identifier.uri | https://doi.org/10.1002/hep.31046 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/62411 | |
dc.identifier.wosid | WOS:000528749200001 | |
dc.information.autoruc | Escuela de medicina ; Arab Verdugo, Juan Pablo ; 0000-0002-8561-396X ; 132745 | |
dc.information.autoruc | Escuela de medicina ; Ibacache Figueroa, Mauricio Enrique ; 0000-0003-3627-5834 ; 817 | |
dc.issue.numero | No. 2 | |
dc.language.iso | en | |
dc.nota.acceso | contenido parcial | |
dc.pagina.final | 453 | |
dc.pagina.inicio | 441 | |
dc.revista | HEPATOLOGY | es_ES |
dc.rights | acceso restringido | |
dc.subject.ddc | 610 | |
dc.subject.dewey | Medicina y salud | es_ES |
dc.subject.ods | 03 Good Health and Well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.subject.other | Enfermedades hepáticas | es_ES |
dc.subject.other | Inmunoglobulinas | es_ES |
dc.subject.other | Hepatitis -Terapia | es_ES |
dc.title | An Open-Label, Dose-Escalation Study to Assess the Safety and Efficacy of IL-22 Agonist F-652 in Patients With Alcohol-associated Hepatitis | es_ES |
dc.type | artículo | |
dc.volumen | Vol. 72 | |
sipa.codpersvinculados | 132745 | |
sipa.codpersvinculados | 817 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- An OpenLabelDoseEscalation Study to Assess the Safety and Efficacy of IL22 Agonist F652 in Patients With Alcoholassociated Hepatitis.pdf
- Size:
- 84.33 KB
- Format:
- Adobe Portable Document Format
- Description: